Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: Cancer, Infectious diseases, and Laboratory services. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the cancer field, and the infectious diseases field. The laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has a regulatory approval from Singaporeâs Ministry of Health for molecular microbiology testing for COVID-19 in Singapore.
More about the company